ArticleClinicoEconomics and outcomes research : CEOR2020

US Budget Impact Model for Selinexor in Relapsed or Refractory Multiple Myeloma.

Jan Bassali et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.